Safety and Feasibility of Dasatinib and Quercetin in Adults at Risk for Alzheimer's Disease
Clinical trial NCT05422885 · COMPLETED
Trial details
- NCT number
- NCT05422885
- Sponsor
- Lewis Lipsitz
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-20
- Primary completion
- 2024-01-24
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.